Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Takeda partners with Cour for celiac disease immune therapy

Executive Summary

Takeda Pharmaceutical Co. Ltd. and Cour Pharmaceutical Development Co. Inc. partnered to develop treatments for celiac disease and other gastrointestinal conditions based on Cour's immune-based technology.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register